| Genesis Report-Rx |
| Title | Subject | Authors |
|---|
| 7Future directions in pain management research-talk from the front line. | Health care industry | |
| Acute mycardial infarction-what treatment changes can we expect by 2010. | Health care industry | |
| Acute myocardial infarction: now treated successfully in multiple ways.(Brief Article) | Health care industry | |
| After the genome, proteomics coming of age.(Brief Article) | Health care industry | |
| Allergic rhinitis: innovation opportunities are still plentiful.(Brief Article) | Health care industry | |
| Alzheimer's disease: diagnosis and current treatment: a terrible dilemma.(Brief Article) | Health care industry | |
| A megamerger that will happen: 1998 finally produces a big one.(Brief Article) | Health care industry | |
| Amgen, Biogen, Chiron: early biotechs now in the top 50 Rx.(Brief Article) | Health care industry | |
| Amyotrophic lateral sclerosis: deadlier than multiple sclerosis.(Brief Article) | Health care industry | |
| Antibacterials - Competitive Business Activity by Indication. | Health care industry | |
| Antiobiotic resistance: will the genome project lead to man's victory?(Brief Article) | Health care industry | |
| Antisence: the first marketable fruit.(Brief Article) | Health care industry | |
| Antisense: fulfilled promise is close at hand.(Brief Article) | Health care industry | |
| Asthma management: more help is on the way.(Brief Article) | Health care industry | |
| AstraZeneca: a vault into the top 5 worldwide.(Brief Article) | Health care industry | |
| Cancers in women: 2000-2020 will be a decade of change.(Brief Article) | Health care industry | |
| Cancers of the GI system: the next decade holds new Rx hopes.(Brief Article) | Health care industry | |
| Cancers of the skin; malignant melanoma and Kaposi's sarcoma.(Brief Article) | Health care industry | |
| Cancer: the big four: they account for almost 60% of all new cases.(Brief Article) | Health care industry | |
| Cancer therapy management-current and emerging in vitro diagnostic technologies. | Health care industry | |
| Cancer therapy management-current and emerging in vivo diagnostic technologies. | Health care industry | |
| Can HIV/AIDS Be Treated By Boosting the Immune Response?(A Gloomy Assessment Leads to New approaches to HIV Therapy)(Abstract) | Health care industry | |
| Cardiovascular Disease: Four New Therapies.(Special Report; 11 articles discussing cardiovascular drug sales, and new heart therapies)(Abstract)(Statistical Data Included)(Industry Overview) | Health care industry | |
| Cardiovascular gene therapy: more activity, more diseases, more optimism.(Brief Article) | Health care industry | |
| Clinical Management of Hyperlipidemia and Atherosclerosis. | Health care industry | |
| Companies Use Ribozymes For Therapy and Research.(Cometitive Strategies; Immusol and Innovir Laboratories developing such treatments)(Abstract)(Statistical Data Included) | Health care industry | |
| Consumer Advertisements: How To Spend $3.75 Billion.(Competitive Strategies)(Abstract)(Statistical Data Included) | Health care industry | |
| current management of hypertension-overview of evidence-based standards for management. | Health care industry | |
| Depression: current therapy and what we can expect.(Brief Article) | Health care industry | |
| Depression-reduction of practice variability: PCP vs. specialist.(Brief Article) | Health care industry | |
| Dermatological markets, multiple opportunities, multiple technologies, multiple dollars.(Brief Article) | Health care industry | |
| Dermatological therapeutics- a host of entries and billions in sales. | Health care industry | |
| Dermatological therapeutics- multiple pathways; multiple targets. | Health care industry | |
| Diabetes, needs/gaps in current treatment.(Brief Article) | Health care industry | |
| Diabetic retinopathy: it affects over 25% of all diabetes sufferers.(Brief Article) | Health care industry | |
| Drug discovery and diagnostic targets in synergy. | Health care industry | |
| Dysfunctions of the immune system--Crohn's Disease and IBS.(irritable bowel syndrome)(Illustration)(Statistical Data Included) | Health care industry | |
| Genetic vaccines and genetic antisinse-the horizon is not yet bright. | Health care industry | |
| Gynecological infections--future therapies: plenty of activity and plenty of needs.(Illustration)(Statistical Data Included) | Health care industry | |
| Hepatitis B-vaccines and two drugs are all we have. | Health care industry | |
| Hepatitis C.(The Chief Cause of Liver Transplants) | Health care industry | |
| HIV/AIDS - Will Gene Therapy Provide the Next Breakthrough? | Health care industry | |
| Hypertension-still searching after all those years. | Health care industry | |
| Incontinence - Almost 10 Million Women Suffer This Condition. | Health care industry | |
| Incontinence: another problem that plagues the aging.(Brief Article) | Health care industry | |
| Infertility: about 15% of couples may experience it. | Health care industry | |
| Leukemia: immunotherapy is improving outlook. | Health care industry | |
| Menopausal disorders. | Health care industry | |
| Migraine headache, a higher risk for stroke.(Brief Article) | Health care industry | |
| Molecular medicine- code blockers and intrabodies are not yet headliners. | Health care industry | |
| Molecular medicine: we will see breakthroughs this decade.(Brief Article) | Health care industry | |
| Monoclonal Antibodies - Development and Innovative Opportunities in Oncology. | Health care industry | |
| New Dopamine Agonists Improve Parkinson's Disease Therapy.(Abstract) | Health care industry | |
| New Products Could Double The Dermatology Market by 2007.(Special Report)(Abstract)(Statistical Data Included) | Health care industry | |
| New Therapies Emerge for Metastatic Colon Cancer.(Abstract) | Health care industry | |
| New Therapies Emerge for Peripheral Artery Disease.(Special Report.)(Abstract) | Health care industry | |
| Not currently OTC--potential switches in therapeutic areas now Rx. | Health care industry | |
| Noteworthy: a rose is a rose.(Brief Article) | Health care industry | |
| Noteworthy.(Hormone Replacement-New Options) | Health care industry | |
| Noteworthy: Neurology - Stem Cells and Parkinson's Disease - New Hope? | Health care industry | |
| Noteworthy.(Phenylpropanolamine and Hemorrhagic Stroke in Women) | Health care industry | |
| Noteworthy: resistance problems emerging with some HIV drug therapies.(Brief Article) | Health care industry | |
| Noteworthy: Respiratory Syncytial Virus (RSV).(Brief Article) | Health care industry | |
| Noteworthy.(Utility of Nutrition-Related Technologies for Osteoporosis Therapy) | Health care industry | |
| Not invented here: the old bromide has run its course, probably forever.(Brief Article) | Health care industry | |
| Osteoporosis- therapeutic technologies forecast. | Health care industry | |
| Parkinson's Disease: domographics demand better treatments.(Brief Article) | Health care industry | |
| Pharmaceutical management of hypertension-platform strategies and innovative activity. | Health care industry | |
| Pharmacogenomics, genotyping, phenotyping...clinical trials will never be the same.(Brief Article) | Health care industry | |
| Progress in Three Areas In Breat Cancer Therapy.(Emerging Technologies; cancer treatments)(Abstract) | Health care industry | |
| Respiratory distress syndrome-life threatening in both adults and infants. | Health care industry | |
| Ribozymes-still trying after all those years. | Health care industry | |
| Rx antiviral development: spurred on by HIV.(Brief Article) | Health care industry | |
| Schizophrenia.(Brief Article) | Health care industry | |
| Schizophrenia--many believe it is the worst disease.(Illustration)(Statistical Data Included) | Health care industry | |
| Sleep disorders: no failed antihistimines need apply.(Brief Article) | Health care industry | |
| Stroke-Boomers can only swell already bad numbers. | Health care industry | |
| Stroke: the major cause of disability among adults. | Health care industry | |
| The Latest Drug Merger. Will Two Second-Tier Firms Make One Strong Company?(Competitive Strategies; merger of American Home Products and Monsanto)(Abstract) | Health care industry | |
| Transplantation update.(Brief Article) | Health care industry | |
| Ulcerative colitis therapeutics. | Health care industry | |
| Vaccines: the promise of loss toxic, more effective cancer therapy. | Health care industry | |
| Will Pharmacogenomics Change Drug Development?(Emerging Technologies; industry overview)(Abstract) | Health care industry | |
| With Product Research Intensifying, Are Natural Drugs Ready for Harvest?(Abstract) | Health care industry | |
| Women's health care: endometriosis-vexing, misunderstood, and, so far, incurable.(Brief Article) | Health care industry | |
| Wound care, band-aids need not apply.(Brief Article) | Health care industry | |
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
